Jim M. Koeller
- Oncology top 5%
- Surgery top 10%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Infectious Diseases top 10%
- Co-authors
- Rudolph M. NavariChristopher R. FreiRobert H. EarhartSteven M. GrunbergPaul J. HeskethDouglass C. TormeyGeoffrey R. WeissJohn G. Kuhn
- Topics
- Cancer Treatment and Pharmacology (19 papers)Nausea and vomiting management (9 papers)Cancer therapeutics and mechanisms (8 papers)
- Partner nations
- United StatesAustraliaDenmark
In The Last Decade
Jim M. Koeller
75 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 110
- Oncology 658
- Surgery 382
- Molecular Biology 304
- Pulmonary and Respiratory Medicine 201
- Infectious Diseases 192
Countries citing papers authored by Jim M. Koeller
This map shows the geographic impact of Jim M. Koeller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jim M. Koeller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jim M. Koeller more than expected).
Fields of papers citing papers by Jim M. Koeller
This network shows the impact of papers produced by Jim M. Koeller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jim M. Koeller. The network helps show where Jim M. Koeller may publish in the future.
Co-authorship network of co-authors of Jim M. Koeller
This figure shows the co-authorship network connecting the top 25 collaborators of Jim M. Koeller. A scholar is included among the top collaborators of Jim M. Koeller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jim M. Koeller. Jim M. Koeller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 14 | |
| 4 | 13 | |
| 5 | New drugs not major cost drivers for lung cancer care | 1 |
| 6 | 19 | |
| 7 | 26 | |
| 8 | 43 | |
| 9 | 22 | |
| 10 | 3 | |
| 11 | 46 | |
| 12 | 0 | |
| 13 | 150 | |
| 14 | 2 | |
| 15 | 16 | |
| 16 | 4 | |
| 17 | Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose schedule. | 12 |
| 18 | Phase I study of combination therapy with platinum analogues: Cis-platin (CDDP) and carboplatin (CBDCA) | 0 |
| 19 | 8 | |
| 20 | Iv dichloromethylene diphosphonate in cancer-associated hypercalcemia: a phase I-II evaluation. | 24 |
About Jim M. Koeller
Jim M. Koeller is a scholar working on Oncology, Applied Microbiology and Biotechnology and Infectious Diseases, having authored 80 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (19 papers), Nausea and vomiting management (9 papers) and Cancer therapeutics and mechanisms (8 papers). The work is most often cited by research in Oncology (658 citations), Applied Microbiology and Biotechnology (24 citations) and Infectious Diseases (192 citations). Jim M. Koeller has collaborated with scholars based in United States, Australia and Denmark. Frequent co-authors include Rudolph M. Navari, Christopher R. Frei, Robert H. Earhart, Steven M. Grunberg, Paul J. Hesketh, Douglass C. Tormey, Geoffrey R. Weiss, John G. Kuhn, Kendra D. Tutsch and T.D. Brown. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.